133 related articles for article (PubMed ID: 31168251)
1. Accuracy of CT Scan in Predicting the Surgical PCI in Patients Undergoing Cytoreductive Surgery with/without HIPEC-a Prospective Single Institution Study.
Goswami G; Kammar P; Mangal R; Shaikh S; Patel MD; Bhatt A
Indian J Surg Oncol; 2019 Jun; 10(2):296-302. PubMed ID: 31168251
[TBL] [Abstract][Full Text] [Related]
2. The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Rawert FL; Luengas-Würzinger V; Claßen-Gräfin von Spee S; Baransi S; Schuler E; Carrizo K; Dizdar A; Mallmann P; Lampe B
Arch Gynecol Obstet; 2022 Nov; 306(5):1665-1672. PubMed ID: 35357582
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of MRI for staging peritoneal metastases in patients with colorectal cancer after neoadjuvant chemotherapy.
Rijsemus CJV; Kok NFM; Aalbers AGJ; Buffart TE; Fijneman RJA; Snaebjornsson P; Engbersen MP; Lambregts DMJ; Beets-Tan RGH; Lahaye MJ
Eur J Radiol; 2022 Apr; 149():110225. PubMed ID: 35255321
[TBL] [Abstract][Full Text] [Related]
4. Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures.
Low RN; Barone RM; Lucero J
Ann Surg Oncol; 2015 May; 22(5):1708-15. PubMed ID: 25201499
[TBL] [Abstract][Full Text] [Related]
5. Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC.
Biacchi D; Accarpio F; Ansaloni L; Macrì A; Ciardi A; Federici O; Spagnoli A; Cavaliere D; Vaira M; Sapienza P; Sammartino P
J Surg Oncol; 2019 Dec; 120(7):1208-1219. PubMed ID: 31531879
[TBL] [Abstract][Full Text] [Related]
6. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
7. Diagnostic accuracy of
Feng Z; Liu S; Ju X; Chen X; Li R; Bi R; Wu X
Quant Imaging Med Surg; 2021 Aug; 11(8):3392-3398. PubMed ID: 34341717
[TBL] [Abstract][Full Text] [Related]
8. Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index.
Bhatt A; Rousset P; Benzerdjeb N; Kammar P; Mehta S; Parikh L; Goswami G; Shaikh S; Kepenekian V; Passot G; Glehen O
Colorectal Dis; 2020 Dec; 22(12):2123-2132. PubMed ID: 32940414
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopy and Computed Tomography Imaging in Advanced Ovarian Tumors: A Roadmap for Prediction of Optimal Cytoreductive Surgery.
El-Agwany AS
Gynecol Minim Invasive Ther; 2018; 7(2):66-69. PubMed ID: 30254940
[TBL] [Abstract][Full Text] [Related]
11. Small Bowel PCI Score as a Prognostic Factor of Ovarian Cancer Patients Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a Retrospective Analysis of 130 Patients.
Iavazzo C; Fotiou A; Psomiadou V; Lekka S; Katsanos D; Spiliotis J
Indian J Surg Oncol; 2021 Jun; 12(2):258-265. PubMed ID: 34295068
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
van 't Sant I; van Eden WJ; Engbersen MP; Kok NFM; Woensdregt K; Lambregts DMJ; Shanmuganathan S; Beets-Tan RGH; Aalbers AGJ; Lahaye MJ
Br J Surg; 2019 Mar; 106(4):491-498. PubMed ID: 30353920
[TBL] [Abstract][Full Text] [Related]
13. Adding Value of MRI over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction.
Lin CN; Huang WS; Huang TH; Chen CY; Huang CY; Wang TY; Liao YS; Lee LW
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33917997
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
15. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
[TBL] [Abstract][Full Text] [Related]
16. Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Munoz-Zuluaga CA; Sardi A; Sittig M; Gushchin V; King MC; Nieroda C; Lopez-Ramirez F; Diaz-Montes TP
Int J Surg Oncol; 2020; 2020():1467403. PubMed ID: 33381312
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate.
Cashin PH; Dranichnikov F; Mahteme H
J Surg Oncol; 2014 Aug; 110(2):203-6. PubMed ID: 24846340
[TBL] [Abstract][Full Text] [Related]
18. Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer.
Di Donna MC; Cucinella G; Zaccaria G; Lo Re G; Crapanzano A; Salerno S; Giallombardo V; Sozzi G; Fagotti A; Scambia G; Laganà AS; Chiantera V
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672451
[TBL] [Abstract][Full Text] [Related]
19. Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO).
Bhatt A; Sinukumar S; Mehta S; Damodaran D; Zaveri S; Kammar P; Mishra S; Parikh L; Ranade R; Penumadu P; Rajan F
Eur J Surg Oncol; 2019 Apr; 45(4):666-671. PubMed ID: 30661922
[TBL] [Abstract][Full Text] [Related]
20. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
